Synthesis and biological evaluation of thiosemicarbazone derivatives.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01784-y
- By:
- Publication type:
- Article
Works matching IS 13570560 AND DT 2022 AND VI 39 AND IP 10
Results: 20
1
2
Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01779-9
- By:
- Publication type:
- Article
3
Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
4
Network pharmacology-based study on apigenin present in the methanolic fraction of leaves extract of Cestrum nocturnum L. to uncover mechanism of action on hepatocellular carcinoma.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01759-z
- By:
- Publication type:
- Article
5
Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trial.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01754-4
- By:
- Publication type:
- Article
6
The role of PIP5K1A in cancer development and progression.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01753-5
- By:
- Publication type:
- Article
7
STARD5 as a potential clinical target of hepatocellular carcinoma.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01750-8
- By:
- Publication type:
- Article
8
Molecular perspective on targeted therapy in breast cancer: a review of current status.
- Published in:
- 2022
- By:
- Publication type:
- journal article
9
Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through β-catenin signaling in oral squamous cell carcinoma.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01746-4
- By:
- Publication type:
- Article
10
A pharmacological exploration of targeted drug therapy in non-small cell lung cancer.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01744-6
- By:
- Publication type:
- Article
11
Variants of ERCC5 and the outcome of platinum-based regimens in non-small cell lung cancer: a prospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
12
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01739-3
- By:
- Publication type:
- Article
13
GANT61/BI-847325 combination: a new hope in lung cancer treatment.
- Published in:
- 2022
- By:
- Publication type:
- journal article
14
Epialleles and epiallelic heterogeneity in hematological malignancies.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01737-5
- By:
- Publication type:
- Article
15
c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
16
Bioinformatic analysis identifies epidermal development genes that contribute to melanoma progression.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01734-8
- By:
- Publication type:
- Article
17
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells.
- Published in:
- 2022
- By:
- Publication type:
- journal article
18
Comprehensive transcriptomic and co-expression analysis of ABL1 gene and molecularly targeted drugs in hepatocellular carcinoma based on multi-database mining.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01730-y
- By:
- Publication type:
- Article
19
Message in hand: the application of CRISPRi, RNAi, and LncRNA in adenocarcinoma.
- Published in:
- Medical Oncology, 2022, v. 39, n. 10, p. 1, doi. 10.1007/s12032-022-01727-7
- By:
- Publication type:
- Article
20
Unraveling the therapeutic potential of GANT61/Dactolisib combination as a novel prostate cancer modality.
- Published in:
- 2022
- By:
- Publication type:
- journal article